{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:04:49Z","timestamp":1788285889914,"version":"build-2803163510"},"reference-count":50,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC-Human Immunology Unit"}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,7,8]]},"abstract":"<jats:p>\n                    Virus-based tumour vaccines offer many advantages compared to other antigen-delivering systems. They generate concerted innate and adaptive immune response, and robust CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell responses. We engineered a non-replicating pseudotyped influenza virus (S-FLU) to deliver the well-known cancer testis antigen, NY-ESO-1 (NY-ESO-1 S-FLU). Intranasal or intramuscular immunization of NY-ESO-1 S-FLU virus in mice elicited a strong NY-ESO-1-specific CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell response in lungs and spleen that resulted in the regression of NY-ESO-1-expressing lung tumour and subcutaneous tumour, respectively. Combined administration with anti-PD-1 antibody, NY-ESO-1 S-FLU virus augmented the tumour protection by reducing the tumour metastasis. We propose that the antigen delivery through S-FLU is highly efficient in inducing antigen-specific CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell response and protection against tumour development in combination with PD-1 blockade.\n                  <\/jats:p>","DOI":"10.7554\/elife.76414","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T09:15:13Z","timestamp":1659690913000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.76414","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors"],"prefix":"10.7554","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7734-4600","authenticated-orcid":true,"given":"Matheswaran","family":"Kandasamy","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-9204","authenticated-orcid":true,"given":"Uzi","family":"Gileadi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Rijal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiong Kit","family":"Tan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian N","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine and Translational Gastroenterology Unit, Peter Medawar Building, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Chen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Prota","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine and Translational Gastroenterology Unit, Peter Medawar Building, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Townsend","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cerundolo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/2326-6066.CIR-19-0554","article-title":"Self-maintaining CD103+ cancer-specific T cells are highly energetic with rapid cytotoxic and effector responses","volume":"8","author":"Abd Hamid","year":"2020","journal-title":"Cancer Immunology Research"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nature Immunology"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00646","article-title":"Cross-protective potential and protection-relevant immune mechanisms of whole inactivated influenza virus vaccines are determined by adjuvants and route of immunization","volume":"10","author":"Bhide","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.4049\/jimmunol.1202665","article-title":"A new model for CD8+ T cell memory inflation based upon A recombinant adenoviral vector","volume":"190","author":"Bolinger","year":"2013","journal-title":"Journal of Immunology"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/irv.12142","article-title":"Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration","volume":"7","author":"Budimir","year":"2013","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"E590","DOI":"10.1002\/ijc.29118","article-title":"NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus","volume":"136","author":"Chen","year":"2015","journal-title":"International Journal of Cancer"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00304","article-title":"Anti-tumor activity of toll-like receptor 7 agonists","volume":"8","author":"Chi","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.4049\/jimmunol.171.10.5116","article-title":"High avidity antigen-specific CTL identified by CD8-independent tetramer staining","volume":"171","author":"Choi","year":"2003","journal-title":"Journal of Immunology"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100127","article-title":"CD103+CD8+ TRM cells accumulate in tumors of anti-PD-1-responder lung cancer patients and are tumor-reactive lymphocytes enriched with tc17","volume":"1","author":"Corgnac","year":"2020","journal-title":"Cell Reports Medicine"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.221","article-title":"Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer","volume":"12","author":"Errico","year":"2015","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"Journal of Virology"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the chadox1 ncov-19 vaccine against SARS-cov-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2017.12.025","article-title":"A recombinant antibody-expressing influenza virus delays tumor growth in A mouse model","volume":"22","author":"Hamilton","year":"2018","journal-title":"Cell Reports"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.166.3.1813","article-title":"Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections","volume":"166","author":"Hogan","year":"2001","journal-title":"Journal of Immunology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"14453","DOI":"10.1073\/pnas.0606512103","article-title":"Recombinant vaccinia\/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients","volume":"103","author":"J\u00e4ger","year":"2006","journal-title":"PNAS"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1128\/JVI.07025-11","article-title":"Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lung","volume":"86","author":"Jennrich","year":"2012","journal-title":"Journal of Virology"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005754","article-title":"RIG-I signaling is critical for efficient polyfunctional T cell responses during influenza virus infection","volume":"12","author":"Kandasamy","year":"2016","journal-title":"PLOS Pathogens"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/jnci\/84.14.1084","article-title":"Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine","volume":"84","author":"Kantor","year":"1992","journal-title":"Journal of the National Cancer Institute"},{"key":"bib19","first-page":"676","article-title":"Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus","volume":"59","author":"Kass","year":"1999","journal-title":"Cancer Research"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.4049\/jimmunol.181.6.4188","article-title":"Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination","volume":"181","author":"Kaufman","year":"2008","journal-title":"Journal of Immunology"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3945\/jn.109.111864","article-title":"Oral administration of 3,3\u2019-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB\/c mice","volume":"139","author":"Kim","year":"2009","journal-title":"The Journal of Nutrition"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/14760584.2018.1541407","article-title":"Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine","volume":"17","author":"Korenkov","year":"2018","journal-title":"Expert Review of Vaccines"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLOS ONE"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav4275","article-title":"Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis","volume":"5","author":"Liu","year":"2019","journal-title":"Science Advances"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61679-8","article-title":"Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice","volume":"10","author":"Luo","year":"2020","journal-title":"Scientific Reports"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1075114","article-title":"Repeated PD-1\/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer","volume":"5","author":"Mall","year":"2016","journal-title":"Oncoimmunology"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003218","article-title":"Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy","volume":"9","author":"McAuliffe","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.18632\/oncotarget.26680","article-title":"Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice","volume":"10","author":"Neukirch","year":"2019","journal-title":"Oncotarget"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer","volume":"117","author":"Newman","year":"2020","journal-title":"PNAS"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.virusres.2015.07.013","article-title":"Development and applications of single-cycle infectious influenza A virus (sciiav)","volume":"216","author":"Nogales","year":"2016","journal-title":"Virus Research"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nature Reviews. Cancer"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41416-020-0956-x","article-title":"Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model","volume":"123","author":"Philippou","year":"2020","journal-title":"British Journal of Cancer"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1128\/JVI.01820-12","article-title":"Pseudotyped influenza A virus as A vaccine for the induction of heterotypic immunity","volume":"86","author":"Powell","year":"2012","journal-title":"Journal of Virology"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1099\/jgv.0.001228","article-title":"A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge","volume":"100","author":"Powell","year":"2019","journal-title":"The Journal of General Virology"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00577","article-title":"4-1BB agonism combined with PD-L1 blockade increases the number of tissue-resident CD8+ T cells and facilitates tumor abrogation","volume":"11","author":"Qu","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s1074-7613(04)00021-4","article-title":"The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection","volume":"20","author":"Ray","year":"2004","journal-title":"Immunity"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"American Journal of Epidemiology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"PNAS"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1016\/j.vaccine.2018.09.031","article-title":"Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy","volume":"36","author":"Sayedahmed","year":"2018","journal-title":"Vaccine"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/annonc\/mdx179","article-title":"Pattern recognition receptors: immune targets to enhance cancer immunotherapy","volume":"28","author":"Shekarian","year":"2017","journal-title":"Annals of Oncology"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002544","article-title":"Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide","volume":"9","author":"Shenderov","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021937","article-title":"Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against ph1n1 challenge in mice","volume":"6","author":"Soboleski","year":"2011","journal-title":"PLOS ONE"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/jvi.78.6.2666-2673.2004","article-title":"Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors","volume":"78","author":"Sumida","year":"2004","journal-title":"Journal of Virology"},{"key":"bib45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 based immunotherapy of cancer: current perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1099\/jgv.0.000702","article-title":"Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery","volume":"98","author":"Townsend","year":"2017","journal-title":"The Journal of General Virology"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/sji.12288","article-title":"Induction of local secretory iga and multifunctional CD4","volume":"81","author":"Trondsen","year":"2015","journal-title":"Scandinavian Journal of Immunology"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1073\/pnas.2135379100","article-title":"An adenoviral vector cancer vaccine that delivers a tumor-associated antigen\/CD40-ligand fusion protein to dendritic cells","volume":"100","author":"Zhang","year":"2003","journal-title":"PNAS"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1182\/blood-2009-03-206672","article-title":"PD-1\/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model","volume":"114","author":"Zhang","year":"2009","journal-title":"Blood"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/76414\/elife-76414-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/76414\/elife-76414-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/76414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:03:57Z","timestamp":1697058237000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/76414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":50,"alternative-id":["10.7554\/eLife.76414"],"URL":"https:\/\/doi.org\/10.7554\/elife.76414","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.31.454512","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.07.31.454512","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.76414.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.76414.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.76414.sa2","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e76414"}}